Search Results - Conte, P.

  • Showing 1 - 1 results of 1
Refine Results
  1. 1
    Phase II study of a triple combination of oral vinorelbine, capecitabine and trastuzumab as first-line treatment in HER2-positive metastatic breast cancer

    Phase II study of a triple combination of oral vinorelbine, capecitabine and trastuzumab as first-line treatment in HER2-positive metastatic breast cancer by Chan, Arlene, Conte, P., Petruzelka, L., Tubiana-Mathieu, N., Ganju, V., Llombart, A., Espie, M., Majois, F., Gil, M., Vaissiere, N., Villanova, G.

    Published 2013
    Get full text

Search Tools: